Potential-dependent permeabilization of plasma membrane by the peptide BTM-P1 derived from the Cry11Bb1 protoxin

Biochimica et Biophysica Acta - Biomembranes

Volumn 1788, Issue 2, 2009, Pages 532-537

  Arias, Mauricio ^a   Orduz, Sergio ^a,b   Lemeshko, Victor V ^a  

^a UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^b Unidad de Biología Celular y Molecular   (Colombia)

Author keywords

Cry11Bb protoxin; Hemolysis; Light dispersion; Plasma membrane; Polycation peptide; Pore size

Indexed keywords

AMINO ACID; CRY11BB1; PROTEIN BTM P1; PROTOXIN; UNCLASSIFIED DRUG; VALINOMYCIN;

AMINO ACID SEQUENCE; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL ISOLATION; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; ERYTHROCYTE; HEMOLYSIS; LIGHT SCATTERING; MUSCLE HYPOTONIA; NONHUMAN; OSMOTIC PRESSURE; PRIORITY JOURNAL;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL PROTEINS; BACTERIAL TOXINS; CELL MEMBRANE; ERYTHROCYTES; HEMOLYSIS; MEMBRANE POTENTIALS; POROSITY; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 59449102949     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2008.12.009     Document Type: Article

References (58)

1. Hancock R.E.W., and Chapple D.S. Peptide antibiotics. Antimicrob. Agents Chemother. 43 (1999) 1317-1323
2. Reddy K.V.R., Yedery R.D., and Aranha C. Antimicrobial peptides: premises and promises. Int. J. Antimicrob. Agents 24 (2004) 536-547
3. Hancock R.E.W. Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet, Infect. Dis. 1 (2001) 156-164
4. Toke O. Antimicrobial peptides: new candidates in the fight against bacterial infections. Biopolymers 80 (2005) 717-735
5. Moreira C.K., Rodrigues F.G., Ghosh A., Varotti F., Miranda A., Daffre S., Jacobs-Lorena M., and Moreira L.A. Effect of the antimicrobial peptide gomesin against different life stages of Plasmodium spp. Exp. Parasitol. 116 (2007) 346-353
6. Epand R.M., and Vogel H.J. Diversity of antimicrobial peptides and their mechanisms of action. Biochim. Biophys. Acta 1462 (1999) 11-28
7. Andres E., and Dimarcq J.L. Clinical development of antimicrobial peptides. Int. J. Antimicrob. Agents 25 (2005) 448-452
8. Giuliani A., Pirri G., and Nicoletto S.F. Antimicrobial peptides: an overview of a promising class of therapeutics. Cent. Eur. J. Biol. 2 (2007) 1-33
9. Zaiou M. Multifunctional antimicrobial peptides: therapeutic targets in several human diseases. J. Mol. Med. 85 (2007) 317-329
10. Zelezetsky I., Pag U., Sahl H.-G., and Tossi A. Tuning the biological properties of amphipathic α-helical antimicrobial peptides: rational use of minimal amino acid substitutions. Peptides 26 (2005) 2368-2376
11. Hoskin D.W., and Ramamoorthy A. Studies on anticancer activities of antimicrobial peptides. Biochim. Biophys. Acta 1778 (2008) 357-375
12. Pfeiffer D.R., Gudz T.I., Novgorodov S.A., and Erdahl W.L. The peptide mastoparan is a potent facilitator of the mitochondrial permeability transition. J. Biol. Chem. 270 (1995) 4923-4932
13. Risso A., Braidot E., Sordano M.C., Vianello A., Macri F., Skerlavaj B., Zanetti M., Gennaro R., and Bernardi P. BMAP-28, an antibiotic peptide of innate immunity, induces cell death through opening of the mitochondrial permeability transition pore. Mol. Cell. Biol. 22 (2002) 1926-1935
14. Bernheimer A.W., and Rudy B. Interactions between membranes and cytolytic peptides. Biochim. Biophys. Acta 864 (1986) 123-141
15. Gilbert R.J.C. Pore-forming toxins. Cell. Mol. Life Sci. 59 (2002) 832-844
16. Restrepo N., Gutiérrez D., Patiño M.M., Thiéry I., Delécluse A., and Orduz S. Cloning, expression and toxicity of a mosquitocidal toxin gene of Bacillus thuringiensis subsp. medellin. Mem. Inst. Oswaldo Cruz 92 (1997) 257-262
17. Segura C., Guzman F., Patarroyo M.E., and Orduz S. Activation pattern and toxicity of the Cry11Bb1 toxin of Bacillus thuringiensis subsp. medellin. J. Invertebr. Pathol. 76 (2000) 56-62
18. V.V. Lemeshko, F. Guzman, M.E. Patarroyo, C. Segura, S. Orduz, Synthetic peptide having an ionophoric and antimicrobial activity, U. S. Patent No. 7,041,647 (2005).
19. Lemeshko V.V., Arias M., and Orduz S. Mitochondria permeabilization by a novel polycation peptide BTM-P1. J. Biol. Chem. 280 (2005) 15579-15586
20. Segura C., Guzmán F., Salazar L.M., Patarroyo M.E., Orduz S., and Lemeshko V.V. BTM-P1 polycationic peptide biological activity and 3D-dimensional structure. Biochem. Biophys. Res. Commun. 353 (2007) 908-914
21. Gutierrez P., Alzate O., and Orduz S. A theoretical model of the tridimensional structure of Bacillus thuringiensis subsp. medellin Cry11Bb toxin deduced by homology modelling. Mem. Inst. Oswaldo Cruz 96 (2001) 357-364
22. Glukhov E., Stark M., Burrows L.L., and Deber C.M. Basis for selectivity of cationic antimicrobial peptides for bacterial versus mammalian membranes. J. Biol. Chem. 280 (2005) 33960-33967
23. Schneider D., and Engelman D.M. Motifs of two small residues can assist but are not sufficient to mediate transmembrane helix interactions. J. Mol. Biol. 343 (2004) 799-804
24. Yang L., Harroun T.A., Weiss T.M., Ding L., and Huang H.W. Barrel-stave model or toroidal model? A case of study on melittin pores. Biophys. J. 81 (2001) 1475-1485
25. Epand R.M., and Epand R.F. Lipids domains in bacterial membranes and the action of antimicrobial agents. Biochim. Biophys. Acta (2008) 10.1016/j.bbamem.2008.08.023
26. Houghten R.A. General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. Proc. Natl. Acad. Sci. U. S. A. 82 (1985) 5131-5135
27. N2 deprotection of synthetic peptides with low concentration of HF in dimethyl sulfide: evidence and application in peptide synthesis. J. Am. Chem. Soc. 105 (1983) 6442-6455
28. Raghuraman H., and Chattopadhyay A. Cholesterol inhibits the lytic activity of melittin in erythrocytes. Chem. Phys. Lipids 134 (2005) 183-189
29. Mikkelsen R.B., Tanabe K., and Wallace D.F.H. Membrane potential of Plasmodium-infected erythrocytes. J. Cell Biol. 93 (1982) 685-689
30. Kuga S. Pore size distribution analysis of gel substances by size exclusion chromatography. J. Chromatogr. 206 (1981) 449-461
31. Jimenez-Juarez N., Muñoz-Garay C., Gomez I., Gil S.S., Soberon M., and Bravo A. The pre-pore from Bacillus thuringiensis Cry1Ab toxin is necessary to induce insect death in Manduca Sexta. Peptides 29 (2008) 318-323
32. Schnepf E., Crickmore N., Van Rie J., Lereclus D., Baum J.R., Feitelson J., Zeigler D.R., and Dean D.H. Bacillus thuringiensis and its pesticidal crystal proteins. Microbiol. Mol. Biol. Rev. 62 (1998) 775-806
33. de Maagd R.A., Bravo A., Berry C., Crickmore N., and Schnepf H.E. Structure, diversity, and evolution of protein toxins from spore-forming entomopathogenic bacteria. Annu. Rev. Genet. 37 (2003) 409-433
34. Broderinck N.A., Raffa K.F., and Handelsman J. Midgut bacteria required for Bacillus thuringiensis insecticidal activity. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 15196-15199
35. Zhang X., Candas M., Griko N.B., Taissing R., and Bulla Jr. L.A. A mechanism of cell death involving an adenylyl cyclase/PKA signaling pathway is induced by the Cry1Ab toxin of Bacillus thuringiensis. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 9897-9902
36. Li J., Carroll J., and Ellar D. Crystal structure of insecticidal δ-endotoxin from Bacillus thuringiensis at 2.5 A resolution. Nature 353 (1991) 815-821
37. Gerber D., and Shai Y. Insertion and organization within membranes of the delta-endotoxin pore-forming domain, helix 4-loop-helix 5, and inhibition of its activity by a mutant helix 4 peptide. J. Biol. Chem. 275 (2000) 23602-23607
38. Leetachewa S., Katzenmeier G., and Angsuthanasombat C. Novel preparation and characterization of the alpha4-loop-alpha5 membrane-perturbing peptide from the Bacillus thuringiensis Cry4Ba delta-endotoxin. J. Biochem. Mol. Biol. 39 (2006) 270-277
39. Puntheeranurak T., Uawithya P., Potvin L., Asgsuthanasombat C., and Schwartz J.L. Ion channels formed in planar lipid bilayers by the dipteran-specific Cry4B Bacillus thuringiensis toxin and its alpha1-alpha5 fragment. Mol. Membr. Biol. 21 (2004) 67-74
40. Yudina T.G., Brioukhanov A.L., Zalunin I.A., Revina L.P., Shestakov A.I., Voyushina N.E., Chestukhina G.G., and Netrusov A.I. Antimicrobial activity of different proteins and their fragments from Bacillus thuringiensis parasporal crystals against clostridia and archaea. Anaerobe 13 (2007) 6-13
41. Abe Y., Shimada H., and Kitada S. Raft-targeting and oligomerization of Parasporin-2, a Bacillus thuringiensis crystal protein with anti-tumour activity. J. Biochem. 143 (2008) 269-275
42. Uemori A., Ohgushi A., Yasutake K., Maeda M., Mizuki E., and Ohba M. Parasporin-1Ab, a novel Bacillus thuringiensis cytotoxin preferentially active on human cancer cells in vitro. Anticancer Res. 28 1A (2008) 91-95
43. Quijano J.C., and Lemeshko V.V. Hemoglobin precipitation by polyethylene glycols leads to underestimation of membrane pore sizes. Biochim. Biophys. Acta 1778 (2008) 2775-2780
44. Matsuzaki K. Magainins as paradigm for the mode of action of pore forming polypeptides. Biochim. Biophys. Acta 1376 (1998) 391-400
45. Raghuraman H., and Chattopadhyay A. Melittin: a membrane-active peptide with diverse functions. Biosci. Rep. 27 (2007) 189-223
46. + and calcein release from liposomes and the determination of pore size formed in a membrane. Anal. Sci. 23 (2007) 517-522
47. Eisenberg D. Three-dimensional structure of membrane and surface proteins. Annu. Rev. Biochem. 53 (1984) 595-623
48. Dathe M., and Wieprecht T. Structural features of helical antimicrobial peptides: their potential to modulate activity on model membranes and biological cells. Biochim. Biophys. Acta 1462 (1999) 71-87
49. Leontiadou H., Mark A.E., and Marrink S.-J. Antimicrobial peptides in action. J. Am. Chem. Soc. 128 (2006) 12156-12161
50. Sengupta D., Leontiadou H., Mark A.E., and Marrink S.-J. Toroidal pores formed by antimicrobial peptides show significant disorder. Biochim. Biophys. Acta 1778 (2008) 2308-2317
51. Clark T.M., Koch A., and Moffett D.F. The anterior and posterior 'stomach' regions of larval Aedes aegypti midgut: regional specialization of ion transport and stimulation by 5-hydroxytryptamine. J. Exp. Biol. 202 (1999) 247-252
52. Boudko D.Y., Moroz L.L., Linser P.J., Trimarchi J.R., Smith P.J., and Harvey W.R. In situ analysis of pH gradients in mosquito larvae using non-invasive, self-referencing, pH-sensitive microelectrodes. J. Exp. Biol. 204 (2001) 691-699
53. Ruiz L.M., Segura C., Trujillo J., and Orduz S. In vivo binding of the Cry11Bb toxin of Bacillus thuringiensis subsp. medellin to the midgut of mosquito larvae (Diptera: Culicidae). Mem. Inst. Oswaldo Cruz 99 (2004) 73-79
54. Gazit E., La Rocca P., Sansom M.S.P., and Shai Y. The structure and organization within the membrane of the helices composing the pore-forming domain of Bacillus thuringiensis δ-endotoxin are consistent with an "umbrella-like" structure of the pore. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 12289-12294
55. Whalon M.E., and Wingerd B.A. Bt: mode of action and use. Arch. Insect. Biochem. Physiol. 54 (2003) 200-211
56. Nair M.S., and Dean D.H. All domains of Cry1A toxins insert into insect brush border membranes. J. Biol. Chem. 283 (2008) 26324-26331
57. Tomimoto K., Hayakawa T., and Hori H. Pronase digestion of brush border membrane-bound Cry1Aa shows that almost the whole activated Cry1Aa molecule penetrates into the membrane. Comp. Biochem. Physiol. B, Biochem. Mol. Biol. 144 (2006) 413-422
58. Lemeshko V.V., Arias M., Quijano Perez J.C., and Orduz S. Permeabilization of biomembranes with peptides derived from Cry11Bb protoxin, 51st Biophysical Society Meeting Abstracts. Biophys. J. Supplement (2007) 316a